Samantha Du, Zai Lab CEO (Zai Lab)

Saman­tha Du's Zai Lab inks sur­pris­ing re­search col­lab with Schrödinger for DNA dam­age drug

Head­ed by Saman­tha Du, Chi­nese on­col­o­gy spe­cial­ist Zai Lab has made no qualms about its ag­gres­sive in-li­cens­ing strat­e­gy to dri­ve West­ern drugs in­to re­gion­al mar­kets. That strat­e­gy has been prof­itable so far, but that doesn’t mean Du’s team isn’t will­ing to try some­thing new.

In a sur­pris­ing volte-face, Zai Lab has signed its name to a re­search col­lab­o­ra­tion with physics-based dis­cov­ery out­fit Schrödinger look­ing for an on­col­o­gy can­di­date tar­get­ing the DNA dam­age re­pair path­way, the part­ners said Wednes­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.